Anxiety Disorder Clinical Trial
Official title:
The Effects of Verbal Instructions on Fear Extinction and Extinction Retrieval in Patients With Anxiety Disorders and Healthy Controls
NCT number | NCT05718271 |
Other study ID # | 673 |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | February 2, 2023 |
Est. completion date | August 2024 |
The goal of this study is to examine if verbal instructions can improve fear extinction learning and extinction retrieval in patients with anxiety disorders (AD) and healthy controls.
Status | Recruiting |
Enrollment | 240 |
Est. completion date | August 2024 |
Est. primary completion date | August 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 60 Years |
Eligibility | Inclusion Criteria: - For the patient group: DSM-5 anxiety disorder diagnosis via a structured clinical interview for diagnosing mental disorders (DIPS) - For the healthy controls: no psychological disorder according to the Mini-DIPS Exclusion Criteria: - smoking - alcohol abuse - drug consumption - current and chronic physical and neurological diseases - for the patient group: anxiety not the primary diagnosis, psychological comorbidities e.g. schizophrenia, bipolar disorder, mental retardation, acute drug or alcohol addiction, personality disorder, currently in psychotherapy - for the healthy controls: a diagnosis of psychological disorder at any point in life, ever been in psychotherapy, current and/or regular intake of medicine (incl. psychopharmaceutic medicine), current or past cognitive or neurological disorder - for women: pregnancy, nursing period - previous experience with fear conditioning paradigm |
Country | Name | City | State |
---|---|---|---|
Germany | Ruhr University Bochum | Bochum |
Lead Sponsor | Collaborator |
---|---|
Ruhr University of Bochum |
Germany,
Duits P, Cath DC, Lissek S, Hox JJ, Hamm AO, Engelhard IM, van den Hout MA, Baas JM. Updated meta-analysis of classical fear conditioning in the anxiety disorders. Depress Anxiety. 2015 Apr;32(4):239-53. doi: 10.1002/da.22353. Epub 2015 Feb 20. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Score on Intolerance of Uncertainty Scale | The Intolerance of Uncertainty Scale measures a person's degree of vigilance, burden and disturbed action ability when experiencing uncertain situations. The items are scored on a 5-point scale from 1 = "not at all characteristic of me' to 5 = "entirely characteristic of me" and higher IU scale scores are related to higher intolerance of uncertainty. High IU supposedly plays an important role in maintaining fear and anxiety and is related to poorer fear extinction. | Experimental Day 1 | |
Other | Score on General Self-efficacy (GSE) Scale | The GSE Scale contains ten items and measures how confident the person feels to overcome difficult situations based on their self-assessed competence. The GSE items are scored on a four-point scale with 1 = not at all true, 2 = hardly true, 3 = moderately true and 4 = exactly true. The total score is determined by summing up all item scores, which results in a score between 10 and 40, where the higher scores represent higher GSE. | Experimental Day 1 | |
Other | Trait Anxiety score on State-Trait-Anxiety Inventory | Trait anxiety will be measured with 20 items of the State-Trait Anxiety Inventory. The items are measured on a four-point scale ranging from 1 = hardly ever to 4 = always. The total score of trait anxiety is calculated by summing up the scores (ranging from 20 to 80), whereby higher scores are indicative of higher trait anxiety. | Experimental Day 1 | |
Primary | Fear extinction learning | The difference between the reinforced conditioned stimulus (CS+) and non-reinforced conditioned stimulus (CS-) will be measured on 3 different levels: skin conductance responses (SCRs), CS valence ratings ("How pleasant do you feel when you see this picture?"), and UCS expectancy ratings ("Do you think that this picture is paired with an electrical stimulation?"). | Experimental Day 2 | |
Primary | Extinction retrieval | The difference between the reinforced conditioned stimulus (CS+) and non-reinforced conditioned stimulus (CS-) will be measured on 3 different levels: skin conductance responses (SCRs), CS valence ratings ("How pleasant do you feel when you see this picture?"), and UCS expectancy ratings ("Do you think that this picture is paired with an electrical stimulation?"). | Experimental Day 3 | |
Secondary | Fear acquisition | The difference between the reinforced conditioned stimulus (CS+) and non-reinforced conditioned stimulus (CS-) will be measured on 3 different levels: skin conductance responses (SCRs), CS valence ratings ("How pleasant do you feel when you see this picture?"), and UCS expectancy ratings ("Do you think that this picture is paired with an electrical stimulation?"). | Experimental Day 1 | |
Secondary | Contingency awareness | After fear acquisition, it will be checked if participants can correctly determine which CS had been paired with the UCS. | Experimental Day 1 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06038721 -
Unified Protocol: Community Connections
|
N/A | |
Not yet recruiting |
NCT03224845 -
Courageous Parents, Courageous Children
|
N/A | |
Completed |
NCT02096783 -
Scripted Sexual Health Informational Intervention in Improving Sexual Function in Patients With Gynecologic Cancer
|
N/A | |
Completed |
NCT02145429 -
Preventing Depression in Late Life: A Model for Low and Middle Income Countries
|
N/A | |
Completed |
NCT00794456 -
Association of Passiflora Incarnata L; Crataegus Oxyacantha L and Salix Alba L. on Mild and Moderate Anxiety
|
Phase 3 | |
Terminated |
NCT00896467 -
Psychological and Emotional Impact in Patients Undergoing Treatment For Metastatic Cancer Either in a Clinical Trial or as Standard Off-Trial Therapy
|
N/A | |
Completed |
NCT00252343 -
Efficacy and Safety of SR58611A in Patients With a Generalized Anxiety Disorder
|
Phase 3 | |
Not yet recruiting |
NCT05867823 -
OcupApp: Occupational Self-analysis Intervention Through an Mobile Application
|
N/A | |
Recruiting |
NCT04562324 -
Efficacy of Electroencephalography (EEG) Neurofeedback (NF) for the Treatment of Anxiety Disorder
|
N/A | |
Recruiting |
NCT05989451 -
Adaptation of Individual Dialectical Behavior Therapy Intervention for Transdiagnostic Treatment of Emotional Disorders
|
N/A | |
Not yet recruiting |
NCT05488418 -
Clinical Study of Biomarkers of Stress Resilience: Role of ELK1 and GPR56
|
N/A | |
Not yet recruiting |
NCT03608449 -
Doing More With Less": Optimizing Psychotherapeutic Services in the Mental Health System
|
N/A | |
Completed |
NCT03400397 -
An Effectiveness Study of the Cool Kids Programme
|
N/A | |
Completed |
NCT00025844 -
Fear Conditioning Using Computer-Generated Virtual Reality
|
N/A | |
Completed |
NCT02579928 -
Ketamine Infusion for Adolescent Depression and Anxiety
|
Phase 4 | |
Completed |
NCT02270073 -
The Process Outcome Mindfulness Effects in Trainees (PrOMET)-Study
|
N/A | |
Terminated |
NCT03764644 -
Web-based Attention Bias Modification Treatment for Childhood Anxiety Disorders
|
N/A | |
Completed |
NCT01425619 -
The Effect of Medical Clowns and Topical Anesthetic Cream on Pain and Anxiety in Children Undergoing Allergy Skin Tests
|
N/A | |
Completed |
NCT01721824 -
The Effect of IPS-MA- A Modified Early Supported Employment Intervention for Individuals With Mood or Anxiety Disorders
|
N/A | |
Completed |
NCT01227980 -
Corticotropin-Releasing Hormone Receptor 1 (CRH1) Antagonism in Anxious Alcoholics^
|
Phase 2 |